Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation

NCT06832085 · clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ottawa Heart Institute Research Corporation

Collaborators